AWE
IDXX icon

Avidian Wealth Enterprises’s Idexx Laboratories IDXX Stock Holding History

Avidian Wealth Enterprises’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,258
Closed -$281K – 154
2019
Q1 		$281K Sell
1,258
-5,988
-83% -$1.24M 0.06% 99
2018
Q4 		$1.35M Buy
7,246
+2,542
+54% +$521K 0.47% 26
2018
Q3 		$1.17M Buy
4,704
+447
+11% +$109K 0.37% 29
2018
Q2 		$928K Buy
4,257
+933
+28% +$192K 0.29% 36
2018
Q1 		$636K Buy
+3,324
New +$613K 0.21% 42

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Avidian Wealth Enterprises's IDXX Position: Q2 2019 in Review

Avidian Wealth Enterprises sold out of Idexx Laboratories (IDXX) in Q2 2019, closing a stake of 1,258 shares — an estimated $281K sold.

Avidian Wealth Enterprises first reported a position in IDXX in Q1 2018 and held it in 5 quarters. The position peaked at $1.35M in Q4 2018. 715 funds tracked by Wall St. Rank hold IDXX as of Q2 2019.

  • Avidian Wealth Enterprises reported no remaining Idexx Laboratories position as of Q2 2019 after selling out during the quarter.
  • Avidian Wealth Enterprises sold 1,258 Idexx Laboratories shares in Q2 2019, an estimated $281K.
  • Avidian Wealth Enterprises first reported a position in Idexx Laboratories in Q1 2018 and held it in 5 quarters.
  • Avidian Wealth Enterprises's Idexx Laboratories position peaked at $1.35M in Q4 2018.
  • 715 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2019.

Based on Avidian Wealth Enterprises's 13F filing for Q2 2019, filed 14 Aug 2019.